The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

DiagnoCure Inc.

  • CUR
  • TSX
  • Consumer Products
  • Latest 0.15
  • Currency C$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 8,705
  • Fri Jul 11, 2014 03:43 PM EDT TSX data delayed 15 minutes.
  • Open 0.15
  • Previous Close 0.15
  • High 0.175
  • Low 0.15
  • Bidx0 0.15
  • Askx0 0.17
  • 52-week High08/30 0.30
  • 52-week Low07/08 0.14
  • Beta 0.856
  • Market Cap 6.46M
  • EPS -0.06
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $695,197
  • Earnings $-2,995,697
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-1,848,303
  • Cash $932,703
  • Current Ratio 6.54

12 months ended Apr 30, 2014.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $6,525,804
  • Liabilities $544,739
  • Liabilities-to-Equity Ratio 0.09

Price Ratios

  • Price to Sales 9.29
  • Price to Book n/a
  • Price to Cash Flow -3.49

Event Calendar

Event Last   Next  
Earnings Jun 2 n/a Sep 3 n/a
Surprises Sep 6 -50.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 13, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

DIAGNOCURE INC. is a life sciences company commercializing high-value cancer diagnostic tests.

Related Securities
Symbol Type Latest % Chg

Officers

  • Frederic Boivin Interim C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    Dec 8, 1994
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

4535, Wilfrid-Hamel Blvd
Quebec, QC
G1P 2J7

Phone: (418)-527-6100
Fax: (418)-5270240

communications@diagnocure.com
www.diagnocure.com

Ideas & Discussion

Live Discussion of CUR on StockTwits